Circulating Th22 and Th9 Levels in Patients with Acute Coronary Syndrome

Overview

Journal Mediators Inflamm

Publisher Wiley

Specialties Biochemistry
Pathology

Date 2014 Jan 24

PMID 24453425

Citations 30

Authors

Ying-Zhong Lin

Bang-Wei Wu

Zheng-de Lu

Ying Huang

Ying Shi

Hao Liu

Ling Liu

Qiu-Tang Zeng

Xiang Wang

Qing-Wei Ji

Affiliations

Soon will be listed here.

Abstract

Background: CD4+ T helper (Th) cells play critical roles in the development and progression of atherosclerosis and the onset of acute coronary syndromes (ACS, including acute myocardial infarction (AMI) and unstable angina pectoris (UAP)). In addition to Th1, Th2, and Th17 cells, Th22 and Th9 subsets have been identified in humans. In the present study, we investigated whether Th22 cells and Th9 cells are involved in the onset of ACS.

Methods: The frequencies of Th22 and Th9 cells were detected using a flow cytometric analysis and their related cytokine and transcription factor were measured in the AMI, UAP, stable angina pectoris (SAP), and control groups.

Results: The results revealed a significant increase in the peripheral Th22 number, AHR expression, and IL-22 levels in patients with ACS compared with those in the SAP and control groups. Although there was no difference in the peripheral Th9 number among the four groups, the PU.1 expression and IL-9 levels were significantly increased in patients with ACS compared with the SAP and control groups.

Conclusions: Circulating Th22 and Th9 type responses may play a potential role in the onset of ACS symptom.

Citing Articles

Cellular aspects of immunity involved in the development of atherosclerosis.

Khalaf K, Chamieh M, Welc N, Singh C, Kaouk J, Kaouk A Front Immunol. 2025; 16:1461535.

PMID: 39944697 PMC: 11813763. DOI: 10.3389/fimmu.2025.1461535.

Moving from lipids to leukocytes: inflammation and immune cells in atherosclerosis.

Annink M, Kraaijenhof J, Stroes E, Kroon J Front Cell Dev Biol. 2024; 12:1446758.

PMID: 39161593 PMC: 11330886. DOI: 10.3389/fcell.2024.1446758.

The roles of Th cells in myocardial infarction.

Liu J, Liu F, Liang T, Zhou Y, Su X, Li X Cell Death Discov. 2024; 10(1):287.

PMID: 38879568 PMC: 11180143. DOI: 10.1038/s41420-024-02064-6.

The imbalance of pulmonary Th17/Treg cells in BALB/c suckling mice infected with respiratory syncytial virus-mediated intestinal immune damage and gut microbiota changes.

Liu J, Huang Y, Liu N, Qiu H, Zhang X, Liu X Microbiol Spectr. 2024; 12(6):e0328323.

PMID: 38727214 PMC: 11237571. DOI: 10.1128/spectrum.03283-23.

Molecular and cellular mechanisms of inflammation in atherosclerosis.

Popa-Fotea N, Ferdoschi C, Micheu M Front Cardiovasc Med. 2023; 10:1200341.

PMID: 37600028 PMC: 10434786. DOI: 10.3389/fcvm.2023.1200341.

References

Veldhoen M, Uyttenhove C, Van Snick J, Helmby H, Westendorf A, Buer J . Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat Immunol. 2008; 9(12):1341-6. DOI: 10.1038/ni.1659. View

Tedgui A, Mallat Z . Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev. 2006; 86(2):515-81. DOI: 10.1152/physrev.00024.2005. View

Geboes L, Dumoutier L, Kelchtermans H, Schurgers E, Mitera T, Renauld J . Proinflammatory role of the Th17 cytokine interleukin-22 in collagen-induced arthritis in C57BL/6 mice. Arthritis Rheum. 2009; 60(2):390-5. DOI: 10.1002/art.24220. View

Chang H, Sehra S, Goswami R, Yao W, Yu Q, Stritesky G . The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. Nat Immunol. 2010; 11(6):527-34. PMC: 3136246. DOI: 10.1038/ni.1867. View

Cheng X, Chen Y, Xie J, Yao R, Yu X, Liao M . Suppressive oligodeoxynucleotides inhibit atherosclerosis in ApoE(-/-) mice through modulation of Th1/Th2 balance. J Mol Cell Cardiol. 2008; 45(2):168-75. DOI: 10.1016/j.yjmcc.2008.04.003. View

Yilmaz A, Lochno M, Traeg F, Cicha I, Reiss C, Stumpf C . Emergence of dendritic cells in rupture-prone regions of vulnerable carotid plaques. Atherosclerosis. 2004; 176(1):101-10. DOI: 10.1016/j.atherosclerosis.2004.04.027. View

Yang X, Wang H, Zhao X, Wang L, Lv Q, Wang Q . Th22, but not Th17 might be a good index to predict the tissue involvement of systemic lupus erythematosus. J Clin Immunol. 2013; 33(4):767-74. DOI: 10.1007/s10875-013-9878-1. View

Robertson A, Hansson G . T cells in atherogenesis: for better or for worse?. Arterioscler Thromb Vasc Biol. 2006; 26(11):2421-32. DOI: 10.1161/01.ATV.0000245830.29764.84. View

Xia Q, Xiang X, Patel S, Puranik R, Xie Q, Bao S . Characterisation of IL-22 and interferon-gamma-inducible chemokines in human carotid plaque. Int J Cardiol. 2011; 154(2):187-9. DOI: 10.1016/j.ijcard.2011.10.093. View

10.

Frostegard J, Ulfgren A, Nyberg P, Hedin U, Swedenborg J, Andersson U . Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis. 1999; 145(1):33-43. DOI: 10.1016/s0021-9150(99)00011-8. View

11.

Mallat Z, Gojova A, Brun V, Esposito B, Fournier N, Cottrez F . Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice. Circulation. 2003; 108(10):1232-7. DOI: 10.1161/01.CIR.0000089083.61317.A1. View

12.

Basu R, OQuinn D, Silberger D, Schoeb T, Fouser L, Ouyang W . Th22 cells are an important source of IL-22 for host protection against enteropathogenic bacteria. Immunity. 2012; 37(6):1061-75. PMC: 3678257. DOI: 10.1016/j.immuni.2012.08.024. View

13.

Weyand C, Goronzy J, Liuzzo G, Kopecky S, Holmes Jr D, Frye R . T-cell immunity in acute coronary syndromes. Mayo Clin Proc. 2001; 76(10):1011-20. DOI: 10.4065/76.10.1011. View

14.

Oliveira R, Silva R, Teo F, Mineiro M, Ferreira M, Altemani A . Detection of TCD4+ subsets in human carotid atheroma. Cytokine. 2013; 62(1):131-40. DOI: 10.1016/j.cyto.2013.02.004. View

15.

Zhong Y, Wang X, Ji Q, Mao X, Tang H, Yi G . CD4+LAP + and CD4 +CD25 +Foxp3 + regulatory T cells induced by nasal oxidized low-density lipoprotein suppress effector T cells response and attenuate atherosclerosis in ApoE-/- mice. J Clin Immunol. 2012; 32(5):1104-17. DOI: 10.1007/s10875-012-9699-7. View

16.

Jager A, Dardalhon V, Sobel R, Bettelli E, Kuchroo V . Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J Immunol. 2009; 183(11):7169-77. PMC: 2921715. DOI: 10.4049/jimmunol.0901906. View

17.

Staudt V, Bothur E, Klein M, Lingnau K, Reuter S, Grebe N . Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity. 2010; 33(2):192-202. DOI: 10.1016/j.immuni.2010.07.014. View

18.

Butcher M, Gjurich B, Phillips T, Galkina E . The IL-17A/IL-17RA axis plays a proatherogenic role via the regulation of aortic myeloid cell recruitment. Circ Res. 2012; 110(5):675-87. PMC: 3337709. DOI: 10.1161/CIRCRESAHA.111.261784. View

19.

Whiting D, Hsieh G, Yun J, Banerji A, Yao W, Fishbein M . Chemokine monokine induced by IFN-gamma/CXC chemokine ligand 9 stimulates T lymphocyte proliferation and effector cytokine production. J Immunol. 2004; 172(12):7417-24. DOI: 10.4049/jimmunol.172.12.7417. View

20.

Madhur M, Funt S, Li L, Vinh A, Chen W, Lob H . Role of interleukin 17 in inflammation, atherosclerosis, and vascular function in apolipoprotein e-deficient mice. Arterioscler Thromb Vasc Biol. 2011; 31(7):1565-72. PMC: 3117048. DOI: 10.1161/ATVBAHA.111.227629. View